Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects
Clinical trial NCT00522236 · COMPLETED
Trial details
- NCT number
- NCT00522236
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2007-07-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.